10 CFR 35.2075
§ 35.2075 Records of the release of individuals containing unsealed byproduct material or implants containing byproduct material.
United States · 10 CFR — Energy · Status: effective
Cite this
- Citation
- 10 CFR 35.2075, § 35.2075 Records of the release of individuals containing unsealed byproduct material or implants containing byproduct material, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/37027
- Permanent ID
ys:prov:37027@1- SHA-256
7340e8c65181e12577975d7e0a98ec9ac364e28a62f46e04eb7c71304e041420
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) A licensee shall retain a record of the basis for authorizing the release of an individual in accordance with § 35.75, if the total effective dose equivalent is calculated by—
(1) Using the retained activity rather than the activity administered;
(2) Using an occupancy factor less than 0.25 at 1 meter;
(3) Using the biological or effective half-life; or
(4) Considering the shielding by tissue.
(b) A licensee shall retain a record that the instructions required by § 35.75(b) were provided to a breast-feeding female if the radiation dose to the infant or child from continued breast-feeding could result in a total effective dose equivalent exceeding 5 mSv (0.5 rem).
(c) The records required by paragraphs (a) and (b) of this section must be retained for 3 years after the date of release of the individual.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.